Clinical trial

A Phase 2 Trial of JKN24011 in COPD

NCT07440524

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-08-01

PhasePHASE2

Study timeline

Study start (actual)2024-08-01Date precision: day

Registry last updated2026-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPD (Chronic Obstructive Pulmonary Disease)unresolved

Interventions

JKN24011BIOLOGICAL

PlaceboOTHER

Sponsors & collaborators

Joincare Pharmaceutical Group Industry Co., Ltdlead sponsor

Mapped research locations

ShanghaiChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07440524 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.